Aprepitant Powder for Oral Suspension: Clinical Trials

1 trial of Aprepitant Powder for Oral Suspension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1

Follow this drug Literature Review of Aprepitant Powder for Oral Suspension trials Research Report on Aprepitant Powder for Oral Suspension

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aprepitant for the Treatment of CLIFAHDD
Aprepitant Powder for Oral Suspension - CLIFAHDD, Congenital Contractures of the Limbs and Face, Hypotonia, and Developmental Delay
Early Phase 1RecruitingThe University of Texas Health Science Center at San Antonio52026-10-312026-10-05

Conditions studied

Ataxia (1)  ·  Channelopathies (1)  ·  Disease (1)  ·  Facies (1)  ·  Learning Disabilities (1)  ·  Muscle Hypotonia (1)  ·  Neurodevelopmental Disorders (1)

Sponsors

The University of Texas Health Science Center at San Antonio (1)

Countries

United States (1)

Top investigators

Megan Iammarino, DPT (1)